Immune escape mechanisms of childhood ALL and a potential countering role for DC-like leukemia cells

Cytotherapy

Volumn 4, Issue 2, 2002, Pages 165-175

  Han, P ^a   Story, C ^a   McDonald, T ^a   Mrozik, K ^a   Snell, L ^b  

^a WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^b FLINDERS MEDICAL CENTRE   (Australia)

Author keywords

Acute lymphoblastic leukemia; Dendritic like cell; Immune escape mechanisms

Indexed keywords

B7 ANTIGEN; CD1 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; FLT3 LIGAND; INTERLEUKIN 1ALPHA; INTERLEUKIN 3; INTERLEUKIN 7; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; OKT 3; TUMOR NECROSIS FACTOR ALPHA;

ACUTE LYMPHOCYTIC LEUKEMIA; ARTICLE; CELL ACTIVITY; CELL CULTURE; CELL STIMULATION; CELL STRUCTURE; CELL VIABILITY; CHILD; DENDRITIC CELL; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNE SYSTEM; IMMUNOGENICITY; IMMUNOTHERAPY; LEUKEMIA CELL; LEUKEMIA CELL LINE; LYMPHOCYTE FUNCTION; PHENOTYPE; T LYMPHOCYTE; B LYMPHOCYTE; CELL CYCLE; CELL DIFFERENTIATION; CELL LINE; CYTOLOGY; HEMATOPOIETIC STEM CELL; IMMUNOLOGY; METHODOLOGY;

B-LYMPHOCYTES; CELL CYCLE; CELL DIFFERENTIATION; CELL LINE; DENDRITIC CELLS; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNOTHERAPY; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; T-LYMPHOCYTES;

EID: 0036000602     PISSN: 14653249     EISSN: None     Source Type: Journal    
DOI: 10.1080/146532402317381875     Document Type: Article

References (38)

1. Graft-versus-leukaemia reactions after bone marrow transplantation
2. Pre-B acute lymphoblastic leukemia cells may induce T-cell anergy to alloantigen
3. AML-derived immunomodulatory factor(s) inhibit T cell cytokine secretion and proliferation via inhibition of NF-ATc activation and failure to upregulate c-MYC
4. Protective and therapeutic immunity against leukemia induced by irradiated B7-1 (CD80)-transduced leukemia cells
5. CD80-transfected acute myeloid leukemia cells induce primary allogeneic T-cell responses directed at patient specific minor histocompatibility antigens and leukemia-associated antigens
6. Reversal of tolerance to human MUCI antigen in MUCI transgenic mice immunised with fusions of dendritic and carcinoma cells
7. Bone marrow-derived dendritic cells serve as potent adjuvants for peptide-based antitumor vaccines
8. Dendritic cell vaccines for cancer immunotherapy
9. Human leukaemia-derived dendritic cells: Ex vivo development of specific antileukemic cytotoxicity
10. Generation of dendritic cells expressing bcr-abl from CD34-positive chronic myeloid leukemia percursor cells
11. Human acute myeloblastic leukemia cells differentiate in vitro into mature dendritic cells and induce the differentiation of cytotoxic T cells against autologous leukemias
12. Leukemic dendritic cells generated in the presence of FLT3 ligand have the capacity to stimulate an autologous leukemia-specific cytotoxic T cell response from patients with acute myeloid leukemia
13. Interleukin-7 is a growth factor of precursor B and T acute lymphoblastic leukemia
14. Rapid method for detecting monoclonality in B cell lymphoma in lymph node aspirates using the polymerase chain reaction
15. The use of monoclonal gene rearrangement for detection of minimal residual disease in acute lymphoblastic leukemia
16. Immunosuppressive factors in human cancer
17. Adoptive T-cell therapy for B-cell acute lymphoblastic leukemia: Preclinical studies
18. Co-stimulatory wars: The tumor menace
19. Engagement of CD27 with its ligand CD70 provides a second signal for T cell activation
20. Induction of a CD8 cytotoxic T lymphocyte response by cross priming requires cognate CD4 help
21. Help for inducing cytotoxic T cell response by cross-priming is mediated via CD40 signalling
22. T cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions
23. + cytotoxic T lymphocytes (CTL) but are not required for the maintenance of CTL memory following virus infection
24. CD4 T cell cytokine differentiation: The B cell activation molecule, OX40 ligand, instructs CD4 T cells to express interleukin 4 and upregulates expression of the chemokine receptor. Blr-1
25. Impairment of antigen-presenting cell function in mice lacking expression of OX40 ligand
26. + T cell proliferation and lead to the amplification in vivo of cytotoxic T cell responses
27. Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors
28. Involvement of the CD27-CD70 co-stimulatory pathway in allogeneic T-cell response to follicular lymphoma cells
29. Enhancement of antitumor immunity by expression of CD70 (CD27 ligand) or CD154 (CD40 ligand) costimulatory molecules in tumor cells
30. + cord blood progenitor cells
31. + T-helper and a T-killer cell
32. + T cell reactivity to a model tumor antigen
33. Reciprocal control of T helper cell and dendritic cell differentiation
34. Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo
35. Effect of leukemic cell microenvironment on the differentiation of dendritic cells from normal monocytes: Phenotypic and functional analysis
36. Tumor-infiltrating dendritic cells are defective in their antigen-presenting function and inducible B7 expression in rats
37. S100 positive dendritic cells in human lung tumours associated with cell differentiation and enhanced survival
38. Langerhans cells related to progress in patients with laryngeal carcinoma